A tool-based approach can significantly aid in the harmonization of regulatory requirements, mitigate inadvertent risks, and ...
In this video interview, Vera Pomerantseva, director of product management, RBQM, eClinical Solutions, talks FDA’s latest protocol deviation guidance and potential changes to the draft.
Policy change by the Trump administration now allows the agency to post public notices in the Federal Register and advertise ...
Phase III PRESTIGE-AF trial shows that direct oral anticoagulants significantly lower the risk of ischemic stroke in ...
Discover how evolving clinical trial trends are reshaping patient and site experiences—and the steps sponsors can take to stay ahead—in this conversation with uMotif CEO Steve Rosenberg at SCOPE ...
External control arms, as an integral part of clinical development, present many potential opportunities for sponsors and ...
In this video interview, Vera Pomerantseva, director of product management, RBQM, eClinical Solutions, highlights FDA’s ...
Making the Grade: Registries as Sources of Regulatory-Grade Real-World Evidence (RWE) ...
Making the Grade: Registries as Sources of Regulatory-Grade Real-World Evidence (RWE) ...
Making the Grade: Registries as Sources of Regulatory-Grade Real-World Evidence (RWE) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback